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Table. Associations between gender and carotid endarterectomy outcomes
Death
Time to
surgery
Perioperative
stroke
Myocardial
infarction
Surgical cardiac
complications
Length of
stay, days
Discharge to facility
or home health
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Asymptomatic
Male 1 1 1 1 1 1 1
Female 0.83 (0.70-0.98) NS NS NS 0.90 (0.83-0.97) 0.93 (0.92-0.93) 1.26 (1.20-1.33)
Symptomatic
Male 1 1 1 1 1 1 1
Female NS NS NS NS 0.78 (0.63-0.97) 0.92 (0.90-0.95) 1.18 (1.10-1.28)
*Adjusted for age, emergency surgery, insurance status, race, hospital location, hospital region, hospital teaching status
CI, Conﬁdence interval; NS, not signiﬁcant; OR, odds ratio.
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Objectives: Malpractice litigation and associated costs
are a factor in increasing healthcare expenditures over
recent decades. Serious potential complications accompa-
nying carotid endarterectomy (CEA), along with the pres-
ence of accepted and widely-used alternatives, make this
procedure a target for litigation. The objective of this anal-
ysis was to characterize the medicolegal environment
regarding CEA, including factors determining legal
responsibility.
Methods: The WestLaw database was searched for
medical malpractice related to CEA. Case outcomes,
alleged cause(s) of malpractice, awarded damages, and
other factors in litigation were recorded.
Results: Of 37 jury verdicts and settlements in this
analysis, defendants were found not liable in 25 (67.5%)
cases. The most frequently reported complications were
cerebrovascular accident (CVA) (51.3%) and hypoglossal
nerve injury (27.0%), with other complications including
airway compromise, vocal cord injury, and death. None
of the cases reported myocardial infarction. Cerebral moni-
toring was mentioned in only two cases, while alleged inad-
equate informed consent, delay in diagnosis, and
requirement of additional surgery were present in a consid-
erable proportion. Settlements and jury awards averaged
$895,833 and $1.53M respectively.
Conclusions: CVA and hypoglossal nerve injury are
the most frequently litigated complications of CEA. While
the majority of decisions found physicians not liable,
damages that were awarded were considerable, exceeding
$1.5M, suggesting that characterization of factors in deter-
mining legal responsibility can help surgeons minimize
liability as well as improve patient safety. The importanceof explicitly listing these complications in informed consent
may restrict liability, as may other steps such as periopera-
tive cerebral monitoring in order to reduce injuries from
a delay in CVA diagnosis.
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Objectives: To report on the incidence of neurological
complications following CEA in patients affected by carotid
stenosis with contralateral occlusion (CO), to analyze
factors associated to neurological complications in this
group of patients, and to compare results between those
patients and the whole group of patients submitted to
CEA at our Vascular Division.
Design: retrospective review of a prospectively-
collected single-center database.
Methods: From January 1997 to November 2012
one-thousand-six-hundreds-eighty-two patients were
consecutively submitted to CEA. 139 presented a CO
contralateral to the carotid stenosis.
The two groups of patients were analyzed and
compared respect to neurological death rates, major and
minor stroke rates and TIA rates. Factors potentially
affecting neurological results were analyzed and compared
within each group and between groups. Statistical signiﬁ-
cance was set at P # .05.
Results: Patients with CO were more frequently male,
smokers, younger, and symptomatic than those without
CO (P < .02). They presented more frequently a preoper-
ative brain infarct and associated peripheral arterial disease
(P < .001).
Patients with CO presented higher overall and major
neurological complications rates compared to patients
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P ¼ .009 respectively).
Factors associated to the highest risk in patients with
CO were age >74 years and presence of preoperative brain
infarct (P < .04). The association of CO, age >74 ys and
preoperative brain infarct signiﬁcantly increase the risk of
post-CEA neurological complication occurrence in the
population submitted to CEA (OR, 21.9; 95% CI, 6.6-
74; P < .0001).
Conclusions: Patients presenting a carotid stenosis
with CO are at high neurological risk when submitted to
CEA. In this group of patients those presenting >74 years
of age and a preoperative brain infarct represent a subset at
highest neurological risk following CEA.
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Objectives: Outcome analysis for carotid endarterec-
tomy (CEA) and carotid angioplasty and stenting (CAS)
using administrative data is hampered by difﬁculty in distin-
guishing pre-existing conditions (eg symptomatic carotid
stenosis) from postoperative complications (eg stroke).
We evaluated whether the introduction of the present on
admission (POA) indicator improved the accuracy of
administrative databases.
Methods: State inpatient databases from CA, NY and
NJ from 2005-2008 were used to identify patients under-
going CAS and CEA. Procedural complications were iden-
tiﬁed using ICD-9 complication codes (eg 997.02,
postoperative stroke). Preoperative conditions were identi-
ﬁed using ICD-9 diagnosis codes (eg, 433.11, carotid
stenosis with infarction). We ﬁrst analyzed the data
without, and then with the POA information.
Results: We identiﬁed 36,002 patients who under-
went CEA and 5682 patients who underwent CAS.
Without POA info, the complication code for stroke indi-
cated a postoperative stroke rate of 1.1% for CEA and
1.9% for CAS. After applying the POA indicator, only
59% (CEA) and 50% (CAS) of these actually referred to
perioperative strokes while the remainder were POA and
thus represented pre-existing strokes. POA info high-
lighted inaccuracies in morbidity data for both complica-
tion and diagnosis codes (Table).
Conclusions: The assumption that complication
codes following CAS or CEA refer to perioperative adverse
events proved to be incorrect, as great proportions appear
to have been POA. The reclassiﬁcation of indications and
complications raise concerns about the validity of adminis-
trative data.Table.
CEA CASRate w/o
POA info POA, %Rate w/o
POA info POA, %Stroke complication code 1.1 41 1.9 50
Cardiac complication code 2.3 45 2.5 50
Stroke diagnosis codes 5.7 86 10.6 87
TIA diagnosis codes 1.9 92 2.5 83
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Objectives: Patients in CREST had duplex ultrasound
(DU) scans prior to treatment (PRE) and during follow-up
(FU) to document the severity of carotid disease and the
outcome of endarterectomy (CEA) or stenting (CAS).
An ultrasound core laboratory (UCL) reviewed DU data
from the clinical sites. This analysis was done to determine
the agreement between site-reported and UCL-veriﬁed
DU velocity measurements.
Methods: Clinical site DU worksheets and images
for the treated carotid arteries were reviewed at the
UCL. The highest internal carotid artery peak systolic
velocity (PSV) and associated Doppler angle were veri-
ﬁed. If the angle was misaligned by >3 degrees, it was
remeasured and PSV recalculated. Agreement for PSV
was deﬁned as site-reported PSV within 65% of UCL-
veriﬁed PSV. Transcription errors were corrected by the
UCL but were not considered as disagreements. FU
